BBVA USA’s Boston Scientific BSX Stock Holding History

BBVA USA’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$37K	Hold	843	–	–	﹤0.01%	698
2021 Q2	$36K	Buy	+843	New	+$35.5K	﹤0.01%	719

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

BBVA USA's BSX Position: Q3 2021 in Review

BBVA USA held its Boston Scientific (BSX) position steady in Q3 2021 at 843 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

BBVA USA first reported a position in BSX in Q2 2021 and has held it in 2 quarters since. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

BBVA USA held 843 shares of Boston Scientific worth $37K as of Q3 2021.
BBVA USA left its Boston Scientific share count unchanged in Q3 2021.
Boston Scientific made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #698 holding.
BBVA USA first reported a position in Boston Scientific in Q2 2021 and has held it in 2 quarters since.
877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.